Mvision AI Oy
About Mvision AI Oy
Mvision AI Oy, a Helsinki-based healthcare AI company founded in 2017, specializes in developing advanced AI-powered solutions to enhance the efficiency and impact of cancer care, particularly in radiation therapy. The company’s core offerings are cloud-based software services that automate and standardize critical steps in radiotherapy treatment planning.
Their flagship products include Contour+, an AI-powered auto-contouring software, and Dose+, an FDA 510(k) cleared solution for AI-powered dose prediction in personalized radiotherapy treatment planning. These tools, along with Guide for training and Verify for accuracy assessment, are designed to streamline workflows by significantly reducing manual effort in tasks like organ-at-risk (OAR) contouring, potentially by up to 95%. This automation aims to cut down treatment waiting times from weeks to days, facilitating same-day cancer treatment. Mvision AI’s solutions are clinically evaluated, integrate seamlessly with existing DICOM-compliant treatment planning systems, and have been utilized in treating over 190,000 cancer patients across more than 22 countries.
For physicians, Mvision AI’s technology offers a means to achieve greater consistency and standardization in radiotherapy planning, reduce inter-planner variability, and free up valuable clinical time for more complex tasks and patient-focused care. The company is committed to continuous innovation, developing new solutions to further accelerate treatment processes and build a globally scalable cloud-based platform for cancer care.
Focus Areas
Business Intelligence
| Key Investors | J12 Ventures, Voima Ventures, Icebreaker.VC, Nuard Ventures, Business Finland R&D |
| Partnerships | Baylor College of Medicine (research and development agreement), Philips (working on agreement for Contour+ Access™ with CT Simulators), Tecnosan (distribution partnership), Turku University Hospital, Docrates Cancer Center, Kuopio University Hospital, National Cancer Center Singapore |
| Technology | Cloud-based AI solutions, Deep learning models, DICOM-compliant integration, AI-powered auto-segmentation, Machine learning-based dose prediction |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, MVision AI's solutions offer significant advantages by drastically reducing manual workload and increasing efficiency in treatment planning, freeing up valuable time for patient-facing tasks and potentially shortening patient waiting times from weeks to days. The AI models, trained on international guidelines, ensure improved consistency and quality of treatment plans, leading to more standardized and accurate contours and dose predictions, thereby reducing inter-planner variability and errors. This enhanced clinical confidence is supported by clinically validated solutions that provide reliable starting points for planning and aid in informed decision-making. The comprehensive anatomical coverage across over 300 structures reduces the need for manual delineation across various cancer sites. Furthermore, the seamless integration into existing clinical workflows minimizes disruption, and adherence to GDPR and HIPAA standards ensures robust patient data security and privacy.
MVision AI's solutions, including Contour+ and Dose+, are designed for seamless integration with all major radiotherapy treatment planning systems (TPS) through standard DICOM protocols. They offer both cloud-based deployment, allowing for easy and fast updates of AI algorithms, and local solutions to address stricter data protection regulations.
What the Web Says
MVision AI Oy is a Helsinki-based company specializing in AI-driven auto-segmentation services for radiation therapy and cancer care. Their solutions aim to streamline treatment planning, automate manual tasks, and improve treatment quality, ultimately allowing patients to receive treatment faster. The company has received FDA 510(k) Clearance for its guideline-based segmentation solution in the US and has expanded its services to new countries outside the EU and US. MVision AI has been recognized for its rapid growth, ranking among the top ten in the Deloitte Technology Fast 50 Finland 2024. They offer a comprehensive suite of products, including Contour+, Guide, and Verify, which are designed to enhance contouring accuracy, standardize practices, and reduce treatment planning time.
Overall: PositiveStrengths
- Streamlines clinical workflow and reduces contouring time significantly.
- Enhances the quality and precision of radiation therapy.
- Provides reliable and consistent contours, improving treatment quality.
- Integrates seamlessly with existing clinical workflows and hospital systems.
- Offers a comprehensive solution with AI-powered auto-contouring, guideline training, and contour assessment tools.
- Strong commitment to transforming cancer care and expanding access to life-saving treatments.
Limitations
- One Reddit user mentioned that MVision AI might be struggling in the US market.
- Some general downsides of AI vision tools include the need for a lot of data and training, which can be time-consuming and expensive, and potential struggles with unusual conditions or lighting.
- One user on Reddit preferred other products like Limbus for accuracy and workflow.
Based on reviews from: Google Search, Reddit, Indeed.com, Capterra, G2
Last updated: 2026-07-18
Videos
News, demos, and interviews about Mvision AI Oy.
Videos load interactively. If none appear, search YouTube for Mvision AI Oy →
Press & Coverage
Frequently Asked Questions
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]